Notice of Closed Meeting, 43845-43846 [2020-15615]
Download as PDF
<![CDATA[
43845
Federal Register / Vol. 85, No. 139 / Monday, July 20, 2020 / Notices
transfer of biological agents or toxins
that have the potential to pose a severe
threat to animal or plant health, or
animal or plant products (select agents
and toxins). Accordingly, HHS and
USDA have promulgated regulations
requiring individuals or entities that
possess, use, or transfer select agents
and toxins to register with the CDC or
the Animal and Plant Health Inspection
Service (APHIS). See 42 CFR part 73, 7
CFR part 331, and 9 CFR part 121 (the
select agent regulations). The Federal
Select Agent Program (FSAP) is the
collaboration of the CDC, Division of
Select Agents and Toxins (DSAT) and
the APHIS Agriculture Select Agent
Services (AgSAS) to administer the
select agent regulations in a manner to
minimize the administrative burden on
persons subject to the select agent
regulations. The FSAP administers the
select agents regulations in close
coordination with the Federal Bureau of
Investigation’s Criminal Justice
Information Services (CJIS).
Accordingly, CDC and APHIS have
adopted an identical system to collect
information for the possession, use, and
transfer of select agents and toxins.
CDC is requesting OMB approval to
continue to collect information under
the select agent regulations through the
use of five forms: (1) Application for
Registration for Possession. Use, and
Transfer of Select Agents and Toxins
(APHIS/CDC Form 1); (2) Request to
Transfer Select Agents or Toxins
(APHIS/CDC Form 2); (3) Incident
Notification and Reporting (Theft, Loss,
or Release) (APHIS/CDC Form 3); (4)
Reporting the Identification of a Select
Agent or Toxin (APHIS/CDC Form (4);
and (5) Request for Exemption of Select
Agents and Toxins for an Investigational
Product (APHIS/CDC Form 5).
An entity may amend its registration
(42 CFR 73.7(h)(1)) if any changes occur
to the information previously submitted
to CDC. When applying for an
amendment to a certificate of
registration, an entity would complete
the relevant portion of the application
package (APHIS/CDC Form 1).
Besides the forms listed above, there
is no standard form for the following
information:
1. An individual or entity may request
an exclusion from the requirements of
the select agent regulations of an
attenuated strain of a select agent or a
select toxin modified to be less potent
or toxic. (42 CFR 73.3(e) and 73.4(e)).
2. Annual inspections that are
conducted by the entity must be
documented. (42 CFR 73.9(a)(6)).
3. An individual’s security risk
assessment may be expedited upon
written request by a Responsible Official
and a showing of good cause. (42 CFR
73.10(f)).
4. An individual or entity may request
approval to perform a ‘‘restricted
experiment’’ (42 CFR 73.13).
5. An individual or entity must
develop and implement a written
security plan, biosafety plan, and
incident response plan (42 CFR 73.11(a),
42 CFR 73.12(a), and 42 CFR 73.14(a)).
6. The Responsible Official at the
entity must ensure a record of the
training for each individual with access
to select agents and toxins and each
escorted individual is maintained (42
CFR 73.15(d)).
7. An individual or entity may appeal
a denial, revocation, or suspension of
registration. (42 CFR 73.20(a)).
8. An individual may appeal a denial,
limitation, or revocation of access
approval. (42 CFR 73.20(b)).
The total estimated annualized
burden for all data collection was
calculated using the 2018 Annual
Report of the Federal Select Agent
Program available at https://
www.selectagents.gov/
annualreport2018.html or FSAP IT
system and is estimated as 4467 hours.
Information will be collected through
FSAP IT system, fax, email and hard
copy mail from respondents. Upon OMB
approval, CDC will begin use of the
revised forms in October 2020 through
October 2023. There is no cost to the
respondents.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Section
Form name
Sections 3 & 4 ............
Sections 5 & 6 ............
Sections 5 & 6 ............
Section 7 .....................
Section 7 .....................
Section 9 .....................
Section 10 ...................
Section 11 ...................
Section 12 ...................
Section 13 ...................
Section 14 ...................
Section 15 ...................
Section 16 ...................
Section 17 ...................
Section 19 ...................
Section 20 ...................
Request for Exclusions .......................................................................
Report of Identification of a Select Agent or Toxin ............................
Request of Exemption ........................................................................
Application for Registration ................................................................
Amendment to a Certificate of Registration .......................................
Documentation of self-inspection .......................................................
Request for Expedited Review ...........................................................
Security Plan ......................................................................................
Biosafety Plan .....................................................................................
Request Regarding a Restricted Experiment .....................................
Incident Response Plan .....................................................................
Training ...............................................................................................
Request to Transfer Select Agents and Toxins .................................
Records ..............................................................................................
Notification of Theft, Loss, or Release ...............................................
Administrative Review ........................................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2020–15655 Filed 7–17–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
VerDate Sep<11>2014
18:30 Jul 17, 2020
Jkt 250001
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
1
1,181
1
3
253
253
1
253
253
1
253
253
253
253
201
28
Number of
responses per
respondent
1
1
1
1
5
1
1
1
1
1
1
1
1
1
1
1
Average
burden per
response
(in hours)
1
1
1
5
1
1
0.5
1
1
2
1
1
1.5
0.5
1
1
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
E:\FR\FM\20JYN1.SGM
20JYN1
43846
Federal Register / Vol. 85, No. 139 / Monday, July 20, 2020 / Notices
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463.
Name of Committee: Safety and
Occupational Health Study Section
(SOHSS), National Institute for
Occupational Safety and Health
(NIOSH).
Date: October 20–21, 2020.
Time: 11:00 a.m.–5:00 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to
address matters related to the conduct of
Study Section business and for the
study section to consider safety and
occupational health-related grant
applications.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific
Review Officer, NIOSH, 1095
Willowdale Road, Morgantown, WV
26506, (304) 285–5951; MGoldcamp@
cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–15615 Filed 7–17–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–20–20IP]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Occupational
Driver Safety at Intersections’’ to the
Office of Management and Budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on February 25, 2020 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
VerDate Sep<11>2014
18:30 Jul 17, 2020
Jkt 250001
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Occupational Driver Safety at
Intersections—New—National Institute
for Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
The mission of the National Institute
for Occupational Safety and Health
(NIOSH) is to promote safety and health
at work for all people through research
and prevention. Nearly 40% of all traffic
crashes occur at intersections.
Erroneous decision-making while
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
crossing a signalized intersection is a
significant risk factor for drivers. Such
decision-making is even more
challenging for occupational drivers
(e.g., police and fire truck drivers) due
to their job demands, special vehicle
characteristics, and frequency of crash
risk exposure. NIOSH has initiated a
laboratory simulation study on effects of
occupation, vehicle type, vehicle
approach speed, signal light logic, and
emergency response status on
emergency vehicle driver decisionmaking at intersections to advance the
safety of approximately 900,000 law
enforcement officers and 1,134,400
career and volunteer firefighters.
Study results will be used to develop
science-based safety recognition training
materials for emergency vehicle drivers
and their employers to enhance driver
safety at intersections. The information
also will be used to (1) determine the
optimal time/distance to activate a
traffic signal preemption system for
emergency vehicles to obtain the rightof-way at intersections, and (2)
conceptualize an advanced driver
assistant system (ADAS) that provides
signal light status and issues a
preemptive warning when an
emergency vehicle approaches an
intersection at an unsafe speed limit
based on the vehicle and environmental
conditions. The system will assist
occupational drivers in decision making
while crossing a signalized intersection.
Thirty-two fire truck drivers, 32 law
enforcement officers (LEOs), and 32
general passenger vehicle drivers will be
recruited for the experiment. The
driving task for fire truck drivers and
LEOs will consist of responding to an
emergency call and returning to the base
station. The general passenger vehicle
drivers serve as the baseline reference;
they will drive a sedan, simulating
normal daily driving conditions. LEOs
will perform an additional driving task
(off-duty condition) using a sedan (same
weight and size as the LEO cruiser) on
a separate visit for the experiment. The
drivers’ performance (e.g., perception
and response time, stopping accuracy,
and stress level) and safety outcomes
(e.g., deceleration at intersection,
clearance to intersection, red light
running time, and red light running
frequency) will be analyzed, based on
vehicle locations, vehicle speeds, and
drivers’ heart rates.
A follow-up study will evaluate the
effectiveness of a driver assistant tool
(derived from the first experiment) on
the drivers’ decision-making and overall
safety outcomes. The driver assistant
tool would be (1) either an algorithm to
activate a traffic signal preemption
system at optimal time/distance for
E:\FR\FM\20JYN1.SGM
20JYN1
]]>Agencies
[Federal Register Volume 85, Number 139 (Monday, July 20, 2020)]
[Notices]
[Pages 43845-43846]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-15615]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Closed Meeting
In accordance with Section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended, and the Determination of the Director, Strategic
Business
[[Page 43846]]
Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant
to Public Law 92-463.
Name of Committee: Safety and Occupational Health Study Section
(SOHSS), National Institute for Occupational Safety and Health (NIOSH).
Date: October 20-21, 2020.
Time: 11:00 a.m.-5:00 p.m., EDT.
Place: Teleconference.
Agenda: The meeting will convene to address matters related to the
conduct of Study Section business and for the study section to consider
safety and occupational health-related grant applications.
FOR FURTHER INFORMATION CONTACT: Michael Goldcamp, Ph.D., Scientific
Review Officer, NIOSH, 1095 Willowdale Road, Morgantown, WV 26506,
(304) 285-5951; [email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-15615 Filed 7-17-20; 8:45 am]
BILLING CODE 4163-18-P
